IMMUNOGLOBULIN G1, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL PF-06741086 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-06741086 .LAMBDA.-CHAIN, DIMER
Hemophilia A or B
Institute of Hematology & Blood Diseases Hospital, Chinamonoclonal_antibodyPhase 2Active
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
17 Active assets in the Hemophilia A or B cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Rfviii Chulalongkorn University | Phase 4 | BB |
Stsp-0601 For Jiangsu BioJeTay Biotechnology Co., Ltd. | Phase 3 | BB |
Ribavirin Kenneth Sherman | Phase 4 | BB |
Activated Prothrombin Complex Concentrate Baxalta now part of Shire | Phase 3 | BB |
Pegylated Interferon Alpha2A Baqiyatallah Medical Sciences University | Phase 4 | BB |
View all 34 →
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL PF-06741086 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-06741086 .LAMBDA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →